Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
- PMID: 29722430
- DOI: 10.1111/apt.14689
Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders
Abstract
Background: Butyrate, propionate and acetate are short chain fatty acids (SCFA), important for maintaining a healthy colon and are considered as protective in colorectal carcinogenesis. However, they may also regulate immune responses and the composition of the intestinal microbiota. Consequently, their importance in a variety of chronic inflammatory diseases is emerging.
Aims: To review the physiology and metabolism of SCFA in humans, cellular and molecular mechanisms by which SCFA may act in health and disease, and approaches for therapeutic delivery of SCFA.
Methods: A PubMed literature search was conducted for clinical and pre-clinical studies using search terms: 'dietary fibre', short-chain fatty acids', 'acetate', 'propionate', 'butyrate', 'inflammation', 'immune', 'gastrointestinal', 'metabolism'.
Results: A wide range of pre-clinical evidence supports roles for SCFA as modulators of not only colonic function, but also multiple inflammatory and metabolic processes. SCFA are implicated in many autoimmune, allergic and metabolic diseases. However, translating effects of SCFA from animal studies to human disease is limited by physiological and dietary differences and by the challenge of delivering sufficient amounts of SCFA to the target sites that include the colon and the systemic circulation. Development of novel targeted approaches for colonic delivery, combined with postbiotic supplementation, may represent desirable strategies to achieve adequate targeted SCFA delivery.
Conclusions: There is a large array of potential disease-modulating effects of SCFA. Adequate targeted delivery to the sites of action is the main limitation of such application. The ongoing development and evaluation of novel delivery techniques offer potential for translating promise to therapeutic benefit.
© 2018 John Wiley & Sons Ltd.
Similar articles
-
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. Epub 2018 Aug 28. J Physiol. 2018. PMID: 30066368 Free PMC article.
-
Short chain fatty acids in human gut and metabolic health.Benef Microbes. 2020 Sep 1;11(5):411-455. doi: 10.3920/BM2020.0057. Epub 2020 Aug 31. Benef Microbes. 2020. PMID: 32865024 Review.
-
Colonic health: fermentation and short chain fatty acids.J Clin Gastroenterol. 2006 Mar;40(3):235-43. doi: 10.1097/00004836-200603000-00015. J Clin Gastroenterol. 2006. PMID: 16633129 Review.
-
Short-chain free-fatty acid G protein-coupled receptors in colon cancer.Biochem Pharmacol. 2021 Apr;186:114483. doi: 10.1016/j.bcp.2021.114483. Epub 2021 Feb 23. Biochem Pharmacol. 2021. PMID: 33631190 Review.
-
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.J Gastroenterol. 2017 Jan;52(1):1-8. doi: 10.1007/s00535-016-1242-9. Epub 2016 Jul 23. J Gastroenterol. 2017. PMID: 27448578 Free PMC article. Review.
Cited by
-
Postbiotics: Current Trends in Food and Pharmaceutical Industry.Foods. 2022 Oct 5;11(19):3094. doi: 10.3390/foods11193094. Foods. 2022. PMID: 36230169 Free PMC article. Review.
-
Short-chain fatty acids ameliorate imiquimod-induced skin thickening and IL-17 levels and alter gut microbiota in mice: a metagenomic association analysis.Sci Rep. 2024 Jul 30;14(1):17495. doi: 10.1038/s41598-024-67325-x. Sci Rep. 2024. PMID: 39079980 Free PMC article.
-
Fecal Levels of Lactic, Succinic and Short-Chain Fatty Acids in Patients with Ulcerative Colitis and Crohn Disease: A Pilot Study.J Clin Med. 2021 Oct 13;10(20):4701. doi: 10.3390/jcm10204701. J Clin Med. 2021. PMID: 34682823 Free PMC article.
-
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.Front Endocrinol (Lausanne). 2021 Nov 8;12:748254. doi: 10.3389/fendo.2021.748254. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34819919 Free PMC article. Review.
-
Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis.Front Nutr. 2022 May 17;9:861854. doi: 10.3389/fnut.2022.861854. eCollection 2022. Front Nutr. 2022. PMID: 35662935 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources